Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 6/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | BRD4 | O60885 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | MAP2K2 | P36507 | 1/20 | 0.31 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ioxitalamic Acid SCHEMBL455411 | 1.00 | LMNA (0.57) | LMNASMN1; SMN2GAABRD4CYP2C19 | |
| SCHEMBL11522720 | 0.92 | LMNA (0.55) | LMNASMN1; SMN2BRD4CYP2C19HIF1A | |
| SCHEMBL11775063 | 0.91 | LMNA (0.51) | LMNASMN1; SMN2GAACYP2C19HIF1A | |
| SCHEMBL11178469 | 0.86 | ALDH1A1 (0.36) | LMNASMN1; SMN2CYP2C19HIF1AMAP2K2 | |
| SCHEMBL9395608 | 0.85 | LMNA (0.46) | LMNASMN1; SMN2BRD4CYP2C19HIF1A | |
| SCHEMBL30881050 | 0.85 | LMNA (0.60) | LMNASMN1; SMN2BRD4CYP2C19HIF1A | |
| SCHEMBL9659222 | 0.85 | LMNA (0.60) | LMNASMN1; SMN2BRD4CYP2C19HIF1A | |
| SCHEMBL11412072 | 0.85 | LMNA (0.41) | LMNASMN1; SMN2TSHRMAPK1 | |
| Ioxitalamic Acid SCHEMBL29730019 | 0.84 | SMN1; SMN2 (0.78) | LMNASMN1; SMN2GAACYP2C19HIF1A | |
| SCHEMBL8610004 | 0.84 | LMNA (0.40) | LMNASMN1; SMN2TSHRMAPK1MAP2K2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12616681-B2 | Compositions and methods for treating renal injury | CASE WESTERN RESERVE UNIVERSITY (US) | 2026-05-05 | — | — | US | claimed |
| EP-3741381-B1 | A PEPTIDE FOR USE FOR PREVENTION AND TREATMENT OF ACUTE RENAL INJURY | UNIV CORNELL (US) | 2024-04-24 | — | — | EP | claimed |
| US-20230398172-A1 | METHODS FOR PREVENTION AND TREATMENT OF ACUTE RENAL INJURY | CORNELL UNIVERSITY (US) | 2023-12-14 | — | — | US | claimed |
| US-11628198-B2 | Methods for prevention and treatment of acute renal injury | CORNELL UNIVERSITY (US) | 2023-04-18 | — | — | US | claimed |
| US-20230052363-A1 | COMPOSITIONS AND METHODS FOR TREATING RENAL INJURY | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-02-16 | — | — | US | claimed |
| US-12616681-B2 | Compositions and methods for treating renal injury | CASE WESTERN RESERVE UNIVERSITY (US) | 2026-05-05 | — | — | US | disclosed |
| WO-2026090048-A1 | RADIOPAQUE SHAPE MEMORY FOAM DEVICES | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| US-20260115330-A1 | RADIOPAQUE MULTI-ARM POLYMERS FOR MEDICAL APPLICATIONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-04-30 | — | — | US | disclosed |
| EP-3484485-B1 | COMPOSTIONS COMPRISING POLOXAMER FOR USE IN THE TREATMENT OF FISTULAE | CENTRE NAT RECH SCIENT (FR) | 2026-04-29 | — | — | EP | disclosed |
| US-20260108250-A1 | RADIOPAQUE SHAPE MEMORY FOAM DEVICES | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260049178-A1 | CROSSLINKING AGENTS AND MEDICAL HYDROGELS FORMED THEREFROM | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-02-19 | — | — | US | disclosed |
| US-20260041799-A1 | HYDROLYSIS-RESISTANT HYDROGELS AND METHODS OF TREATMENT USING SAME | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-02-12 | — | — | US | disclosed |
| US-11931339-B2 | Compositions and methods for treating tissue injury | CASE WESTERN RESERVE UNIVERSITY (US) | 2024-03-19 | — | — | US | disclosed |
| US-20240024297-A1 | COMPOSITIONS AND METHODS FOR TREATING RENAL INJURY | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-01-25 | — | — | US | disclosed |
| US-20230398172-A1 | METHODS FOR PREVENTION AND TREATMENT OF ACUTE RENAL INJURY | CORNELL UNIVERSITY (US) | 2023-12-14 | — | — | US | disclosed |
| US-11628198-B2 | Methods for prevention and treatment of acute renal injury | CORNELL UNIVERSITY (US) | 2023-04-18 | — | — | US | disclosed |
| US-20230052363-A1 | COMPOSITIONS AND METHODS FOR TREATING RENAL INJURY | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-02-16 | — | — | US | disclosed |
| US-20230001128-A1 | AEROSOLIZATION SYSTEMS, METHODS, AND APPARATUSES | SHUSTER GARY STEPHEN (CA) | 2023-01-05 | — | — | US | disclosed |
| EP-4106748-A1 | COMPOSITIONS AND METHODS FOR TREATING RENAL INJURY | CASE WESTERN RESERVE UNIVERSITY (US) | 2022-12-28 | — | — | EP | disclosed |
| US-11389470-B2 | Compositions useful for mucosal healing | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2022-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11628198-B2 | Methods for prevention and treatment of acute renal injury | ARG2, SERPINC1, ARG1 | LMNA 2196/4885SMN1; SMN2 4340/4885GAA 2381/4885 |
| US-20260115330-A1 | RADIOPAQUE MULTI-ARM POLYMERS FOR MEDICAL APPLICATIONS | KLK3, BRDT, BPHL | LMNA 2822/4885SMN1; SMN2 3766/4885GAA 3244/4885 |
| US-20230398172-A1 | METHODS FOR PREVENTION AND TREATMENT OF ACUTE RENAL INJURY | ARG2, SERPINC1, ARG1 | LMNA 2196/4885SMN1; SMN2 4340/4885GAA 2381/4885 |
| US-20260049178-A1 | CROSSLINKING AGENTS AND MEDICAL HYDROGELS FORMED THEREFROM | NPPA, MACF1, IGF1R | LMNA 3574/4885SMN1; SMN2 3009/4885GAA 4766/4885 |
| US-20230052363-A1 | COMPOSITIONS AND METHODS FOR TREATING RENAL INJURY | GLS, REN, PTGS1 | LMNA 1018/4885SMN1; SMN2 3853/4885GAA 985/4885 |
| US-11931339-B2 | Compositions and methods for treating tissue injury | PDK4, AK1, PDK1 | LMNA 1588/4885SMN1; SMN2 2878/4885GAA 2160/4885 |
| US-12616681-B2 | Compositions and methods for treating renal injury | PTGIS, PTGS1, PTGS2 | LMNA 2413/4885SMN1; SMN2 4794/4885GAA 3567/4885 |
| US-20240024297-A1 | COMPOSITIONS AND METHODS FOR TREATING RENAL INJURY | PTGS1, GLS, PTGS2 | LMNA 2612/4885SMN1; SMN2 4231/4885GAA 1418/4885 |
| US-11389470-B2 | Compositions useful for mucosal healing | MUC1, PGF, CD68 | LMNA 3296/4885SMN1; SMN2 4364/4885GAA 3170/4885 |
| US-20260041799-A1 | HYDROLYSIS-RESISTANT HYDROGELS AND METHODS OF TREATMENT USING SAME | PAM, CRYAA, COL1A1 | LMNA 362/4885SMN1; SMN2 1218/4885GAA 958/4885 |
| US-20260108250-A1 | RADIOPAQUE SHAPE MEMORY FOAM DEVICES | NPPA, CD47, PLAT | LMNA 198/4885SMN1; SMN2 2218/4885GAA 3007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.